Universitätsklinikum Bonn

Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience (2019) Pfaff E, El Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, et al. Journal article Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort (2019) Wu W, Jordan S, Graf N, Pena JDO, Curram J, Allanore Y, Matucci-Cerinic M, et al. Journal article Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice (2019) Kühn C, Tauchi M, Furtmair R, Urschel K, Raaz-Schrauder D, Neumann AL, Frohberger SJ, et al. Journal article Topical therapy of psoriasis vulgaris - a treatment pathway (2019) Koerber A, Wilsmann-Theis D, Augustin M, Von Kiedrowski R, Mrowietz U, Rosenbach T, Meller S, et al. Journal article Characterization of esophageal inflammation in patients with achalasia. A retrospective immunohistochemical study (2019) Döhla M, Leichauer K, Gockel I, Niebisch S, Thieme R, Lundell L, Schumacher J, et al. Journal article Growth in disorders and normal variants of puberty (2019) Binder G, Bettendorf M, Dörr HG, Hauffa BP, Reinehr T, Richter-Unruh A, Rohrer TR, Woelfle J Journal article, Review article MRI Brain Signal Intensity and Relaxation Times in Individuals with Prior Exposure to Gadobutrol (2019) Saake M, Schmidle A, Kopp M, Hanspach J, Hepp T, Nagel AM, Dörfler A, et al. Journal article Transcriptome-wide analysis of filarial extract-primed human monocytes reveal changes in LPS-induced PTX3 expression levels (2019) Buerfent BC, Gölz L, Hofmann A, Ruehl H, Stamminger W, Fricker N, Hess T, et al. Journal article Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD (2019) Schlenk RF, Weber D, Fiedler W, Salih HR, Wulf G, Salwender H, Schroeder T, et al. Journal article Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article